期刊文献+

一种高效制备人β2微球蛋白标准物质的方法和应用 被引量:1

An efficient method for the preparation of human β2-microglobulin reference material and its application prospects
下载PDF
导出
摘要 目的构建重组人β2微球蛋白表达体系,高效快速获取β2微球蛋白,为临床实验室检测参考物质的制备奠定基础。方法优化人β2微球蛋白序列,人工合成优化序列片段并与麦芽糖结合蛋白(MBP)分别克隆至pRSF-Duet载体以构建重组人β2微球蛋白表达质粒。使用大肠杆菌E.coli BL21(DE3)对重组质粒进行诱导表达,TEV蛋白酶切除MBP,全自动生化仪测定β2微球蛋白浓度。对重组蛋白在4℃和–20℃储存条件下的稳定性进行检测,对β2微球蛋白纯品与校准品的互通性进行分析。结果成功构建重组人β2微球蛋白表达质粒,异丙基硫代半乳糖苷(IPTG)成功诱导重组蛋白表达,MBP-β2微球蛋白(MBP-β2-MG)浓度可达100 mg/L,β2微球蛋白浓度可达185 mg/L。在4℃和–20℃储存条件下监测64周,β2微球蛋白稳定存在。β2微球蛋白纯品与RANDOX生化校准品互通性良好。结论通过密码子优化,成功构建了重组β2微球蛋白的高效表达系统,β2微球蛋白可溶性高,稳定性好,与国际通用校准品互通性好,可充分满足该产品诊断试剂制备的需求。 Objective To construct optimized human β2-microglobulin prokaryotic expression system, and obtain recombinant β2-microglobulin efficiently and rapidly which is expected to provide basis for the preparation of reference materials and application in quality control in clinical laboratories. Methods The optimized human β2-microglobulin gene was synthesized and cloned into pRSF-Duet vector with maltose binding protein (MBP) to generate MBP-β2-MG pRSF expression vector. Recombinant human β2-MG protein was expressed in E.coli BL21(DE3) and its concentration was analyzed by Hitachi analysis system after MBP was cut by TEV protease. The stability of β2-MG protein was detected during long-term storage at 4℃ and -20 ℃. The compatibility of the purified β2 microglobulin and the β2 microglobulin from RANDOX was analyzed.Results The prokaryotic expression vector MBP-β2-MG pRSF was successfully constructed. When expressed in E.coli BL21(DE3), the concentration of soluble MBP-β2-MG was about 100 mg/L, and the concentration of β2-MG protein could reach 185 mg/L. β2-MG protein was stable after 64 weeks at 4℃ and -20℃. The purified β2 microglobulin had good compatibility with the β2 microglobulin from RANDOX. Conclusions The recombinant MBP- β2-MG protein is soluble and the concentration of β2-MG can reach 185 mg/L, which can fully meet the requirement of the preparation of diagnostic reagent.
作者 邹丽辉 王萌 黄薇 张恩毅 肖飞 王玉梅 ZOU Li-hui;WANG Meng;HUANG Wei;ZHANG En-yi;XIAO Fei;WANG Yu-mei(The MOH Key Laboratory of Geriatrics,Department of Laboratory Medicine,Beijing Hospital,National Center of Gerontology,Beijing 100730,China;Department of Biomaterials,National Institute for Food and Drug Control,Beijing 100050,China)
出处 《中国医药生物技术》 2018年第5期412-417,共6页 Chinese Medicinal Biotechnology
基金 北京市自然科学基金(7172193) “重大新药创制”国家科技重大专项(2017ZX09304026) 国家自然科学基金(81571384)
关键词 Β2微球蛋白 重组蛋白质类 参考物质 Beat2-microglobulin Recombinant proteins Reference material
  • 相关文献

参考文献3

二级参考文献135

  • 1Santin M, Cannas M. Collagen-bound alphal-microglobulin in normal and healed tissues and its effect on immunocompetent cells.Scand J Immunol, 1999,50:289-295.
  • 2Mendez E, Femandez-Luna JL, Grubb A, et al. Human protein H Cand its IgA complex are inhibitors of neutrophil chemotaxis. Proc Natl Acad Sci U S A, 1986,83:1472-1475.
  • 3Allhorn M, Berggard T, Nordberg J, et al. Processing of the lipocalin alpha (1)-microglobulin by hemoglobin induces hemebinding and heme-degradation properties. Blood, 2002, 99 : 1894-1901.
  • 4Moriguchi J, Ezaki T, Tsukahara T, et al. alphal-microglobulin as a promising marker of cadmium-induced tubular dysfunction, possibly better than beta2-microglobulin. Toxicol Lett, 2004,148 : 11-20.
  • 5Calero M, Mendez E, Garcia E. Expression of the human complexforming glycoprotein HC (alphal-microglobulin ) in Escherichia coli.Biochim Biophys Acta, 1995,1249:91-99.
  • 6Wester L, Johansson MU, Akerstrom B. Physicochemical and Biochemical Characterization of Human alphaI-Microglobulin Expressed in Baculovirus Infected Insect Ceils. Protein Expr Purifi,1997, 11:95-103.
  • 7Ekstrom B, Peterson PA, Berggard I. A urinary and plasma alphal-glycoprotein of low molecular weight : isolation and some properties.Biochem Biophys Res Commun, 1975,65 : 1427-1433.
  • 8Geert D’Haens,William J. Sandborn,Brian G. Feagan,Karel Geboes,Stephen B. Hanauer,E. Jan Irvine,Marc Lémann,Philippe Marteau,Paul Rutgeerts,Jurgen Sch?lmerich,Lloyd R. Sutherland.<ce:link locator="fx1"/> A Review of Activity Indices and Efficacy End Points for Clinical Trials of Medical Therapy in Adults With Ulcerative Colitis[J].Gastroenterology.2007(2)
  • 9Susanna Nikolaus,Stefan Schreiber.Diagnostics of Inflammatory Bowel Disease[J].Gastroenterology.2007(5)
  • 10TorstenKucharzik,ChristianMaaser,AndreasLügering,MartinKagnoff,LloydMayer,StephanTargan,WolframDomschke.Recent understanding of IBD pathogenesis: Implications for future therapies[J].Inflamm Bowel Dis.2006(11)

共引文献20

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部